Featured Article

Where is RBQM Heading in The Future With AI?

Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials. With experience at both CluePoints and Veeva, Young discusses AI’s role, transparency, and the future of risk management in clinical trials.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Download
Blog
ICH E6(R3), Demystified: Turning Guidance into Oversight | Part 1
  • The New Era of Good Clinical Practice: A Practical Guide for Sponsors and CROs The updated...
Read More
Press Release
CluePoints Scoops Prestigious 2025 Scrip Award
  • CluePoints Scoops Prestigious 2025 Scrip Award RBQM and AI leader wins the ‘Best Contract Research Organization...
Read More
Blog
How to Elevate Medical Coding with Machine Learning & Deep Learning
  • In most clinical operations today, only 50–60% of medical terms are automatically coded. The rest? Manual...
Read More